The role of liver resection in the management of intermediate and advanced stage hepatocellular carcinoma. A systematic review.

[1]  D. Roukos,et al.  Novel translational therapeutic strategy by sequencing primary liver cancer genomes. , 2017, Future oncology.

[2]  J. Jang,et al.  Long-Term Outcome of Liver Resection Versus Transplantation for Hepatocellular Carcinoma in a Region Where Living Donation is a Main Source. , 2017, Annals of transplantation.

[3]  E. Felekouras,et al.  Ignore reality but not the consequences of its ignorance: Broaden guidelines in surgery of hepatocellular carcinoma , 2017, Hepatology.

[4]  M. Kremer,et al.  Is there a standard for surgical therapy of hepatocellular carcinoma in healthy and cirrhotic liver? A comparison of eight guidelines , 2017, BMJ open gastroenterology.

[5]  Masatoshi Kudo,et al.  Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial , 2017, The Lancet.

[6]  S. Bellentani.  The epidemiology of non‐alcoholic fatty liver disease , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[7]  W. Cho,et al.  From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers , 2017, International journal of molecular sciences.

[8]  G. Torzilli,et al.  Surgery and Hepatocellular Carcinoma , 2016, Liver Cancer.

[9]  B. Du,et al.  Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus , 2016, Medicine.

[10]  Ming Zhang,et al.  Liver resection for intermediate hepatocellular carcinoma. , 2016, World journal of hepatology.

[11]  B. Liu,et al.  Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma. , 2016, World journal of gastroenterology.

[12]  Liqun Wu,et al.  Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma , 2016, BMC Surgery.

[13]  Wei Wei,et al.  Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis , 2016, Oncotarget.

[14]  J. Bruix,et al.  Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. , 2016, Gastroenterology.

[15]  B. Xing,et al.  Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma , 2016, World Journal of Surgical Oncology.

[16]  Young Hwan Kim,et al.  Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis , 2016, Clinical and molecular hepatology.

[17]  Chang Ho Jung,et al.  BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A , 2016, Journal of gastroenterology and hepatology.

[18]  Lequn Li,et al.  Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma , 2015, Medicine.

[19]  E. Hatano,et al.  Hepatic Resection for Hepatocellular Carcinoma with Tumor Thrombus in the Major Portal Vein , 2015, Digestive Surgery.

[20]  E. Cho,et al.  Hepatectomy, combined with intraoperative radiofrequency ablation in patients with multiple hepatocellular carcinomas , 2015, Korean journal of hepato-biliary-pancreatic surgery.

[21]  F. Izzo,et al.  The role of hepatic resection in the treatment of hepatocellular cancer , 2015, Hepatology.

[22]  B. Hamm,et al.  Imaging-Based Liver Function Tests – Past, Present and Future , 2015, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[23]  L. Boni,et al.  Liver resection with thrombectomy as a treatment of hepatocellular carcinoma with major vascular invasion: results from a retrospective multicentric study. , 2015, American journal of surgery.

[24]  X. Qi,et al.  Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies , 2015, Przeglad gastroenterologiczny.

[25]  X. Qi,et al.  Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis , 2015, Oncotarget.

[26]  Chia-Yang Hsu,et al.  Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma , 2015, Journal of surgical oncology.

[27]  Chia-Yang Hsu,et al.  Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma. , 2015 .

[28]  Jung-Hwan Yoon,et al.  Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area , 2015, Journal of gastroenterology and hepatology.

[29]  C. Chen,et al.  Analysis of Prognostic Factors for Survival after Hepatectomy for Hepatocellular Carcinoma Based on a Bayesian Network , 2015, PloS one.

[30]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[31]  Jiang-feng Xu,et al.  Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification , 2015, World Journal of Surgical Oncology.

[32]  Ti Zhang,et al.  The Indications for Hepatectomy for Multinodular Hepatocellular Carcinoma: Experience from a Single Institution , 2015, Digestive Surgery.

[33]  C. Sakakura,et al.  Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis. , 2015, World journal of gastroenterology.

[34]  Lequn Li,et al.  Hepatic Resection as a Safe and Effective Treatment for Hepatocellular Carcinoma Involving a Single Large Tumor, Multiple Tumors, or Macrovascular Invasion , 2015, Medicine.

[35]  M. Zoli,et al.  Prognosis of untreated hepatocellular carcinoma , 2015, Hepatology.

[36]  Lequn Li,et al.  Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus. , 2014, World journal of gastroenterology.

[37]  J. Bruix,et al.  Treatment of intermediate-stage hepatocellular carcinoma , 2014, Nature Reviews Clinical Oncology.

[38]  W. Lau,et al.  Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT. , 2014, Journal of hepatology.

[39]  P. Chow,et al.  Number of Nodules, Child-Pugh Status, Margin Positivity, and Microvascular Invasion, but not Tumor Size, are Prognostic Factors of Survival after Liver Resection for Multifocal Hepatocellular Carcinoma , 2014, Journal of Gastrointestinal Surgery.

[40]  I. Endo,et al.  The efficacy of liver resection for multinodular hepatocellular carcinoma. , 2014, Anticancer research.

[41]  S. Fan,et al.  Surgical Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis , 2014, World Journal of Surgery.

[42]  S. Gallinger,et al.  Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma , 2013, The British journal of surgery.

[43]  N. Yang,et al.  Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[44]  B. Taouli,et al.  Resection of Hepatocellular Carcinoma with Macroscopic Vascular Invasion , 2013, Annals of Surgical Oncology.

[45]  Sheng-Nan Lu,et al.  Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[46]  M. Choti,et al.  A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group , 2013, Annals of surgery.

[47]  Masakazu Yamamoto,et al.  Impact of hepatectomy for huge solitary hepatocellular carcinoma , 2013, Journal of surgical oncology.

[48]  W. Lau,et al.  Surgical Resection Versus Conformal Radiotherapy Combined With TACE for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Comparative Study , 2013, World Journal of Surgery.

[49]  M. Kim,et al.  Role of surgical resection for multiple hepatocellular carcinomas. , 2013, World journal of gastroenterology.

[50]  K. Croome,et al.  Hepatic resection for huge (>15 cm) multinodular HCC with macrovascular invasion. , 2012, The Journal of surgical research.

[51]  Shou-Dong Lee,et al.  Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection? , 2012, Surgery.

[52]  W. Lau,et al.  Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus , 2012, Cancer.

[53]  Guang-shun Yang,et al.  Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma. , 2012, World Journal of Gastroenterology.

[54]  Ke-can Lin,et al.  Evaluation of the clinical features of HCC following hepatectomy for different stages of HCC. , 2012, Hepato-gastroenterology.

[55]  G. Ioannou,et al.  Are Patients with Child's A Cirrhosis and Hepatocellular Carcinoma Appropriate Candidates for Liver Transplantation? , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[56]  M. Zoli,et al.  Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. , 2011, The Lancet. Oncology.

[57]  Minshan Chen,et al.  Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis. , 2011, Radiology.

[58]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[59]  W. Lau,et al.  A new classification for hepatocellular carcinoma with portal vein tumor thrombus , 2011, Journal of hepato-biliary-pancreatic sciences.

[60]  N. Petrucciani,et al.  Does Surgical Resection Have a Role in the Treatment of Large or Multinodular Hepatocellular Carcinoma? , 2010, The American surgeon.

[61]  M. Makuuchi,et al.  Report of the 18th follow‐up survey of primary liver cancer in Japan , 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

[62]  S. Fan,et al.  Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes. , 2010, World journal of gastroenterology.

[63]  Y. Maehara,et al.  Long-Term Results of Hepatic Resection Combined with Intraoperative Local Ablation Therapy for Patients with Multinodular Hepatocellular Carcinomas , 2009, Annals of Surgical Oncology.

[64]  Y. Sakamoto,et al.  Efficacy of a Hepatectomy and a Tumor Thrombectomy for Hepatocellular Carcinoma with Tumor Thrombus Extending to the Main Portal Vein , 2009, Journal of Gastrointestinal Surgery.

[65]  M. D’Onofrio,et al.  Is Liver Resection Justified in Advanced Hepatocellular Carcinoma? Results of an Observational Study in 464 Patients , 2009, Journal of Gastrointestinal Surgery.

[66]  M. Ho,et al.  Liver Resection Improves the Survival of Patients with Multiple Hepatocellular Carcinomas , 2009, Annals of Surgical Oncology.

[67]  Shiuh-Inn Liu,et al.  Is hepatectomy beneficial in the treatment of multinodular hepatocellular carcinoma? , 2008, Journal of the Formosan Medical Association = Taiwan yi zhi.

[68]  Dieter Häussinger,et al.  Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.

[69]  M. Makuuchi,et al.  Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. , 2008, Gastroenterology.

[70]  S. Paik,et al.  Combined Hepatectomy and Radiofrequency Ablation for Multifocal Hepatocellular Carcinomas: Long-term Follow-up Results and Prognostic Factors , 2007, Annals of Surgical Oncology.

[71]  S. Wilhelm,et al.  Discovery and development of sorafenib: a multikinase inhibitor for treating cancer , 2006, Nature Reviews Drug Discovery.

[72]  E. Gregoire,et al.  Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series , 2006, Journal of Gastrointestinal Surgery.

[73]  Bixiang Zhang,et al.  Effects of Location and Extension of Portal Vein Tumor Thrombus on Long-Term Outcomes of Surgical Treatment for Hepatocellular Carcinoma , 2006, Annals of surgical oncology.

[74]  B. Taouli,et al.  Growth Rate of Hepatocellular Carcinoma: Evaluation With Serial Computed Tomography or Magnetic Resonance Imaging , 2005, Journal of computer assisted tomography.

[75]  T. Pawlik,et al.  Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. , 2005, Surgery.

[76]  Ramon Planas,et al.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.

[77]  John Wong,et al.  Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.

[78]  M. Makuuchi,et al.  Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. , 2000, Journal of the American College of Surgeons.

[79]  Jung‐Ta Chen,et al.  An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation. , 2000, Archives of surgery.

[80]  H. Hsu,et al.  Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. , 1985, Gastroenterology.

[81]  E. Ntzani,et al.  The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[82]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[83]  N. Kokudo,et al.  Significance of anatomic resection for early and advanced hepatocellular carcinoma , 2011, Langenbeck's Archives of Surgery.

[84]  Yoon-Koo Kang,et al.  Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. , 2009, The Lancet. Oncology.

[85]  S. Fan,et al.  Hepatic resection for bilobar hepatocellular carcinoma: is it justified? , 2003, Archives of surgery.

[86]  M. Makuuchi,et al.  The Brisbane 2000 terminology of liver anatomy and resections. , 2000 .